艾昆纬年6月比利时和卢森堡月度市场趋势-比利时零售市场（英）

1+ Belgium: Retail+ Belgium: Consumer Health+ Luxembourg: RetailMonthly Belgium and Luxembourg Market Trends June 20252Sales Evolution It shows growth in value and decline in units for the current MAT5001.0001.5002.0002.5003.0003.5004.00002.5575032.749536MNF/EURMAT/06/20222.926568MNF/EURMAT/06/20233.139597MNF/EURMAT/06/20243.377619MNF/EURMAT/06/20253.0593.2853.4943.7363.997MNF/EURMAT/06/2021Sales ex-mnf value (Mio €)ORIGINALGENERIC/COPYMonthly Belgium and Luxembourg Market Trends - June 2025- Not to be published without prior consent IQVIASales EvolutionSales units (Mio)40080100601201401602002201802054UNMAT/06/202114761UNMAT/06/202214565UNMAT/06/2023144135UNMAT/06/202414266UNMAT/06/202568208209211209189ORIGINALGENERIC/COPYThe Belgian retail market is worth € 4 billion in 2025VALUE ex-mnfUNITSSource: IQVIA – LMPB services – Selling In data (registered drugs) 3% of growth versus previous MATRetail market growth evolution BE: original vs generics Monthly Belgium and Luxembourg Market Trends - June 2025- Not to be published without prior consent IQVIA-10-8-6-4-202468107,4%7,5%6,7%MAT/06/20226,4%6,5%5,8%MAT/06/20236,9%7,3%5,2%MAT/06/20247,0%7,6%3,7%MAT/06/2025% of growth in value vs. previous MATTotal MarketORIGINALGENERIC/COPYSource: IQVIA – LMPB services – Selling In data (registered drugs) % of growth versus previous MAT% of growth in units vs. previous MAT-16-14-12-10-8-6-4-20246810121410,0%8,6%13,5%MAT/06/20220,7%-1,3%5,5%MAT/06/20231,0%-0,6%4,7%MAT/06/2024-1,3%-0,9%-1,9%MAT/06/2025Total MarketORIGINALGENERIC/COPYVALUE ex-mnfUNITSIn value, the total retail grows with 07%, while the generic/copy market also shows an increase of 04%The total retail market in units shows a decrease of -01% while the generic/copy market also declines with -02%4Top 10 Best Selling ATC classes in retailUNITSThe top 10 best selling ATC classes in retail in units and value (registered products)Monthly Belgium and Luxembourg Market Trends - June 2025- Not to be published without prior consent IQVIATop 10 Best Selling ATC classes in retailVALUE ex-mnfMNF/EURMAT/06/2025428 M €% of BE Retail Market11%386 M €10%271 M €7%262 M €7%254 M €6%228 M €6%156 M €4%154 M €4%135 M €3%108 M €3%L04 IMMUNOSUPPRESSEURSA10 ANTIDIABETIQUESR03 ANTIASTHM & COPD PRDTSB01 THROMBOLYTIQUESC10 PR LIPID-REGUL A-ATHEROMN02 ANALGESIQUESC09 PROD ACT SYS RENIN-ANGIOJ05 ANTIVIRAUX SYSTEMIQUESN05 PSYCHOLEPTIQUESN07 A.PROD ACT SUR SNCUN MAT/06/202525,810,323% of BE Retail Market12%12,746,5876%10,400,9535%10,048,6405%9,955,8205%9,066,7594%7,696,6484%7,640,3804%6,847,0193%6,508,2533%N02 ANALGESIQUESN05 PSYCHOLEPTIQUESA10 ANTIDIABETIQUESA02 A-ACID.A-FLATUL.A-ULCER.R05 ANTITUSSIFS PREP BRONCHN06 PSYCHO ANALEPTIQUESC10 PR LIPID-REGUL A-ATHEROMJ01 ANTIBACTERIENS SYSTEMIQ.C09 PROD ACT SYS RENIN-ANGIOSource: IQVIA – LMPB services – Selling In data (registered drugs) R01 ANTIINF DECONGEST RHINO5Fastest Growing ATC classes in retailin % growth in UNITSEmerging Trends: Top 10 ATC Categories Showing Growth in Units and